Thomas Hutson

Dec 2, 2024 | nature.com | Jordan W. Squair |Viviana Aureli |Nicholas James |Laetitia Baud |Michael A. Skinnider |Matthieu Gautier | +12 more

AbstractA spinal cord injury (SCI) disrupts the neuronal projections from the brain to the region of the spinal cord that produces walking, leading to various degrees of paralysis. Here, we aimed to identify brain regions that steer the recovery of walking after incomplete SCI and that could be targeted to augment this recovery.

Jun 19, 2024 | nature.com | Michael A. Skinnider |Matthieu Gautier |Claudia Kathe |Thomas Hutson |Achilleas Laskaratos |Viviana Aureli | +7 more

AbstractHere, we introduce the Tabulae Paralytica—a compilation of four atlases of spinal cord injury (SCI) comprising a single-nucleus transcriptome atlas of half a million cells, a multiome atlas pairing transcriptomic and epigenomic measurements within the same nuclei, and two spatial transcriptomic atlases of the injured spinal cord spanning four spatial and temporal dimensions.

May 24, 2024 | targetedonc.com | Sumanta Kumar Pal |Thomas Hutson |Rana R. McKay |Benjamin Gerendash

2 Commerce Drive Cranbury, NJ 08512

May 3, 2024 | targetedonc.com | Sumanta Kumar Pal |Thomas Hutson |Rana R. McKay |Benjamin Gerendash

2 Commerce Drive Cranbury, NJ 08512

Apr 26, 2024 | targetedonc.com | Sumanta Kumar Pal |Thomas Hutson |Rana R. McKay |Benjamin Gerendash

Sumanta Kumar Pal, MD, FASCO, reviews data from the TIVO-3 study investigating tivozanib in patients with advanced renal cell carcinoma, and the panel offers its impressions on the results.